logo-loader
RNS
Transense Technologies

Notice of AGM & Board Changes

RNS Number : 8790A
Transense Technologies PLC
29 October 2026
 

29 October 2026

Transense Technologies plc

("Transense", the "Company" or the "Group")

 

Posting of Annual Report and Notice of AGM and Board changes

 

Posting of Annual Report and Notice of AGM

 

Transense Technologies plc (AIM: TRT), the provider of specialist sensor systems, will today post to shareholders the Company's annual report and accounts for the year ended 30 June 2026 and a circular containing notice of the Company's annual general meeting ("AGM").

 

The AGM will be held on 27 November 2026 at 12 noon at 1 Landscape Close, Weston-on-the-Green, Bicester, Oxfordshire, OX25 3SX.

 

Shareholders wishing to attend in person are invited to arrive at 11:45am.  Those wishing to attend are requested to register at investor.relations@transense.co.uk as soon as possible, and no later than 5pm on 25 November 2026.  As numbers will be limited, this may need to be restricted by invitation on a first come, first served basis, and those able to attend in person will be confirmed by reply email. 

 

In order to allow shareholders to follow the proceedings of the AGM without attending in person, the Company will provide access online via the Investor Meet Company platform. Shareholders are invited to submit questions for the Board to consider. Questions can be pre submitted via the Investor Meet Company platform up until 9am the day before the meeting and can be submitted at any time during the AGM itself.

 

Shareholders will not be able to vote online and are requested to submit their votes via proxy as early as possible. Shareholders that wish to attend the online AGM should register for the event in advance by using the following link: https://www.investormeetcompany.com/transense-technologies-plc/register

 

Investors who already follow TRANSENSE TECHNOLOGIES PLC on the Investor Meet Company platform will automatically be invited.

 

Board changes

 

On 7 July 2026, the Company announced the intended retirement of Melvyn Segal as Chief Financial Officer and Company Secretary with effect from the conclusion of the Annual General Meeting (AGM) in November 2026.  It was his intention to remain on the Board as a non-executive director for a further year.

He has subsequently decided not to seek re-election as a director at the AGM, although he will continue to be employed by the Company in a supporting role until 28 February 2027, and has confirmed his willingness to continue to provide support if required thereafter.  The Board take this opportunity to thank Melvyn for his dedicated years of service to the Company and its shareholders, and wish him a long and enjoyable retirement.

 

As previously announced, Richard Michael Pearce joined the Company on 1 September 2026 to head up the finance function upon Melvyn’s retirement and will join the Board as Finance Director and Company Secretary at the AGM, subject to shareholder approval.  The Board welcomes Richard, and look forward to his continuing contribution to the delivery of the future growth strategy.

 

The Annual Report and Accounts and Notice of AGM will be available later today on the Company's website: www.transense.com.

 

The following additional information is provided with regards to the appointment of Richard Michael Pearce, aged 53, in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

Current directorships/partnerships:

Former directorships/partnerships (within the last five years):

Lombard Medical Limited

N/A

 

Richard holds 11,000 ordinary shares in the Company.

There are no further disclosures required under Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

 

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Richard Pearce (Finance Director)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380 investor.relations@transense.co.uk

 

Notes to Editors:

 

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

 

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

 

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

 

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAKZMZGVRLGVZM
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read